Airsupra — Class II drug recall D-0444-2025
Ongoing recall by AsttraZeneca Pharmaceuticals LP, reported 2025-05-28, distributed nationwide. Defective delivery system
| Recall number | D-0444-2025 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Ongoing |
| Voluntary or mandated | Voluntary |
| Recalling firm | AsttraZeneca Pharmaceuticals LP, Wilmington, DE, United States |
| Recall initiated | 2025-05-14 |
| Classified | 2025-05-21 |
| Reported by FDA | 2025-05-28 |
| Distributed | Nationwide (US) |
| NDC | 00310-9080, 00310-9080-12, 00310-9080-28 |
| Lot numbers | 6270019E00, 6270021D00, 6270095C00 |
| Expiration dates | 2025-07-31, 2025-08-31, 2026-02-28, 2026-10, 2026-11-30, 2026-12-31, 2027-09-30 |
Product
Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
Reason for recall
Defective delivery system
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0444-2025. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.